Literature DB >> 3009868

Novel RNA family structure of hepatitis B virus expressed in human cells, using a helper-free adenovirus vector.

I Saito, Y Oya, H Shimojo.   

Abstract

Ad5-HBL is a type 5 adenovirus bearing the large BglII fragment (2.8 kilobases; 87% of the total genome) of hepatitis B virus (HBV), subtype adr. Eight HBV RNAs expressed in HeLa cells infected with Ad5-HBL were mapped by the nuclease S1 technique. Three major RNAs spanning 2.4, 2.0, and 0.7 kilobases of the HBV sequences cover the coding regions of "presurface" plus surface antigen, surface antigen alone, and "X" protein, respectively. The 5' segment of an RNA which could code for core antigen (HBcAg) was also detected. All major HBV RNAs initiate from mutually exclusive 5' ends, terminate at the unique 3' end within the HBcAg coding region (except readthrough species), and have no spliced deletion, forming a novel RNA family structure. No TATA box-like sequences were found near the 5' end of these RNAs, except in the case of the 2.4-kilobase RNA. About two thirds of total HBV RNA does not terminate at the mapped 3'-end position, suggesting the termination signal is functionally inefficient. Since the potential 5' end of HBcAg mRNA was mapped at the same position as the minus-strand nick of HBV DNA previously reported, we propose a model that requires inefficient poly(A) addition to produce an RNA which serves both as HBcAg mRNA and as the putative RNA template of minus-strand DNA synthesis in the HBV life cycle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009868      PMCID: PMC252944     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40.

Authors:  P K Ghosh; V B Reddy; J Swinscoe; P Lebowitz; S M Weissman
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

2.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Mapping of RNAs transcribed from adenovirus type 12 early and VA RNA regions.

Authors:  I Saito; J Sato; H Handa; K Shiroki; H Shimojo
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

5.  Identification and mapping of two polypeptides encoded within the herpes simplex virus type 1 thymidine kinase gene sequences.

Authors:  C M Preston; D J McGeoch
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

6.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1981-10-24       Impact factor: 16.971

7.  Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA.

Authors:  C Pourcel; A Louise; M Gervais; N Chenciner; M F Dubois; P Tiollais
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

Review 10.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

View more
  11 in total

1.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

2.  Expression of the hepatitis B virus core gene in vitro and in vivo.

Authors:  T Weimer; J Salfeld; H Will
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA.

Authors:  W H Caselmann; M Meyer; A S Kekulé; U Lauer; P H Hofschneider; R Koshy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Expression of processed core protein of hepatitis C virus in mammalian cells.

Authors:  S Harada; Y Watanabe; K Takeuchi; T Suzuki; T Katayama; Y Takebe; I Saito; T Miyamura
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell.

Authors:  C T Bock; P Schranz; C H Schröder; H Zentgraf
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

7.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Identification of a promoter element located upstream from the hepatitis B virus X gene.

Authors:  M Treinin; O Laub
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

9.  Expression of the hepatitis B virus X gene in mammalian cells.

Authors:  A Siddiqui; S Jameel; J Mapoles
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Hepatitis B virus transcript produced by RNA splicing.

Authors:  T S Su; C J Lai; J L Huang; L H Lin; Y K Yauk; C M Chang; S J Lo; S H Han
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.